Yahoo Canada Web Search

Search results

1. • 

     Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q4 2023 Earnings Call Transcript

     Insider Monkey via Yahoo Finance Canada· 2 months ago

     Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB) Q4 2023 Earnings Call Transcript March 1, 2024 Y-mAbs...

2. • Stocks in play: Knight Therapeutics Inc.

     Baystreet via Yahoo Finance Canada· 7 months ago

     Has received pricing approval for Minjuvi® (tafasitamab) from the Drugs Market Regulation Chamber (“CMED”). As a result, Knight expects to launch Minjuvi® in Brazil in the second quarter of ...